Cerebral autoinflammatory disease treated with anakinra
Open Access
- 4 October 2018
- journal article
- research article
- Published by Wiley in Annals of Clinical and Translational Neurology
- Vol. 5 (11) , 1428-1433
Abstract
Interest in autoimmune encephalitis has been growing since the discovery of various autoimmune antibodies, such as N‐methyl D‐aspartate receptors antibody and leucine‐rich glioma‐inactivated 1 antibody. However, in contrast to autoimmune encephalitis associated with dysregulated adaptive immunity in the brain, the question of whether innate immunity‐mediated autoinflammatory diseases exist in the brain has drawn much attention. Herein, we report a patient with microglia‐dominant acute autoinflammatory encephalitis successfully treated with anakinra, an including interleukin‐1 receptor blocker. In comparison to systemic autoinflammatory disease, we term this encephalitis cerebral autoinflammatory disease. Cerebral autoinflammatory disease could suggest new conceptual approaches to patients previously diagnosed with an unspecified encephalitis.Keywords
Funding Information
- National Research Foundation of Korea
- Seoul National University Hospital (3020170130)
This publication has 18 references indexed in Scilit:
- Antibody-Mediated EncephalitisNew England Journal of Medicine, 2018
- Condition-dependent generation of aquaporin-4 antibodies from circulating B cells in neuromyelitis opticaBrain, 2018
- N‐methyl‐D‐aspartate receptor antibody production from germinal center reactions: Therapeutic implicationsAnnals of Neurology, 2018
- Microglia and macrophages in brain homeostasis and diseaseNature Reviews Immunology, 2017
- Steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT): Characteristics, treatment and outcome in 251 cases from the literatureAutoimmunity Reviews, 2016
- A clinical approach to diagnosis of autoimmune encephalitisThe Lancet Neurology, 2016
- Inflammation and white matter degeneration persist for years after a single traumatic brain injuryBrain, 2013
- NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 miceNature, 2012
- Treating inflammation by blocking interleukin-1 in a broad spectrum of diseasesNature Reviews Drug Discovery, 2012
- Inflammation after trauma: Microglial activation and traumatic brain injuryAnnals of Neurology, 2011